Targeted delivery to legumain-expressing cells
US7608591B2 · kind B2 · utility
18Cited by
19References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 29, 2005 |
| Grant date | Oct 27, 2009 |
| Priority date | — |
| Expiry date | Aug 21, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new agents and methods useful for preventing, treating and diagnosing diseases such as cancer. For example, the invention relates to prodrug agents useful for targeting and delivering cytotoxic drugs to cancerous cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.